Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for prevention of propofol-induced hypotension during general anesthesia induction
ChiCTR2200059304Phase 4Not yet recruiting
- Sponsor
- Tumor Hospital Affiliated to Guizhou Medical University
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine and propofol in hypotension (2 arms), sponsored by Tumor Hospital Affiliated to Guizhou Medical University. Primary endpoint: Blood pressure. Planned start Apr 2022; status: not yet recruiting.
02
Drugs
esketaminepropofol
03
Conditions
hypotension
Beyond the preview
Go deeper on ChiCTR2200059304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059304.